Loss Weight Gw-501516 / Gw1516 / 317318-70-0
Alias:2-(4-((2-(4-(Trifluoromethyl)phenyl)-5-methylthiazol-4-yl)methylthio)-2-methylphenoxy)acetic acid; GW1516; GW501516; GSK-516
Usage: It had been investigated as a potential treatment for obesity, diabetes, dyslipidemia and cardiovascular disease. GW501516 could be used by athletes as an ergogenic performance enhancing drug.
We are a direct manufacturer with high quality and competitive price. We have the following SARMs manufactured,
Ostarine, MK-2866, Enobosarm
Enobosarm (Ostarine, MK-2866, GTx-024) - affects both muscle and bone, intended mainly for osteoporosis but also general treatment for andropause and reversing muscle sarcopenia in the elderly and for cachexia in cancer patients.
Pharmacological profile similar to that of enobosarm, Ostarine, MK-2866
MK-677, Ibutamoren, secretagogue, treatment of obesity, a promising therapy for the treatment of frailty in the elderly
Contact person: Rachel
Skype : racheltao5605
MOB: +86 18578209857